-
Donor Organ Utilization And Transplantation Outcomes In Donation After Circulatory Death Using Thoracoabdominal Normothermic Regional Perfusion
-
Donor Terminal Creatinine – Does It Matter?
-
Donor-Derived Carbapenem-Resistant Gram-Negative Infections: Risk Mitigation Strategy in Solid Organ Transplant Improves Recipients Safety and Could Expand Donor Pool
-
Donor-Derived Cell-Free DNA (dd-cfDNA) for Assessment of Response After Treatment of Allograft Rejection
-
Donor-Derived Cell-Free DNA Across the Spectrum of Solid Organ Transplantation
-
Donor-Derived Cell-Free DNA and Gene Expression Profiling for Surveillance of Renal Allograft Injury and Rejection
-
Donor-Derived Cell-Free DNA as a Biomarker of T Cell Mediated Rejection in Pediatric Kidney Transplant Patients
-
Donor-Derived Cell-Free DNA Testing in Kidney Transplantation: Do One-Month Values Have Any Prognostic Significance?
-
Donor-Derived Cell-Free DNA Trends Before and After Rejection Vary Based on Timing of Rejection
-
Donor-Derived Duodenal Adenocarcinoma of a Bladder-Drained Pancreas Allograft
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 190
- Next Page »